Cargando…
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
Diabetic nephropathy (DN) is one of the main causes of renal fibrosis and is associated with high morbidity and mortality. Traditional Chinese Medicine (TCM) therapy has a long history of usage in a clinical setting and its usage is increasing. ErHuang Formula (EHF), a Chinese herbal compound, has b...
Autores principales: | Shen, Yu-Li, Jiang, Yi-ping, Li, Xiao-Qin, Wang, Su-Juan, Ma, Ming-Hua, Zhang, Chun-Yan, Zhu, Jian-Yong, Rahman, Khalid, Zhang, Li-Jun, Luan, Xin, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993046/ https://www.ncbi.nlm.nih.gov/pubmed/32038260 http://dx.doi.org/10.3389/fphar.2019.01596 |
Ejemplares similares
-
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
por: Shen, Yu-Li, et al.
Publicado: (2021) -
CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
por: Sun, Meng-Yao, et al.
Publicado: (2019) -
Mechanism of Erhuang capsule for treatment of multiple sclerosis
por: Li, Kangning, et al.
Publicado: (2013) -
Perspectives of herbs and their natural compounds, and herb formulas on treating diverse diseases through regulating complicated JAK/STAT signaling
por: Chen, Jian-Yu, et al.
Publicado: (2022) -
Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy
por: Zhang, Nanwen, et al.
Publicado: (2021)